New Results
SARS -CoV-2 T-cell immunity to variants of concern following vaccination
Kathleen M.E. Gallagher, Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Y. Yam, Gabrielle Brini, Korneel Grauwet, MGH COVID-19 Collection & Processing Team, Marcela V. Maus
doi: https://doi.org/10.1101/2021.05.03.442455
Kathleen M.E. Gallagher
1Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
3Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA
Mark B. Leick
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
4Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Rebecca C. Larson
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
4Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Trisha R. Berger
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Katelin Katsis
1Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Jennifer Y. Yam
1Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Gabrielle Brini
1Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Korneel Grauwet
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
4Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
4Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
Marcela V. Maus
2Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA
4Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

Posted May 03, 2021.
SARS -CoV-2 T-cell immunity to variants of concern following vaccination
Kathleen M.E. Gallagher, Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Y. Yam, Gabrielle Brini, Korneel Grauwet, MGH COVID-19 Collection & Processing Team, Marcela V. Maus
bioRxiv 2021.05.03.442455; doi: https://doi.org/10.1101/2021.05.03.442455
SARS -CoV-2 T-cell immunity to variants of concern following vaccination
Kathleen M.E. Gallagher, Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Y. Yam, Gabrielle Brini, Korneel Grauwet, MGH COVID-19 Collection & Processing Team, Marcela V. Maus
bioRxiv 2021.05.03.442455; doi: https://doi.org/10.1101/2021.05.03.442455
Subject Area
Subject Areas
- Biochemistry (10821)
- Bioengineering (8064)
- Bioinformatics (27373)
- Biophysics (14020)
- Cancer Biology (11160)
- Cell Biology (16099)
- Clinical Trials (138)
- Developmental Biology (8807)
- Ecology (13329)
- Epidemiology (2067)
- Evolutionary Biology (17394)
- Genetics (11704)
- Genomics (15961)
- Immunology (11057)
- Microbiology (26154)
- Molecular Biology (10679)
- Neuroscience (56724)
- Paleontology (422)
- Pathology (1737)
- Pharmacology and Toxicology (3012)
- Physiology (4567)
- Plant Biology (9665)
- Synthetic Biology (2699)
- Systems Biology (6993)
- Zoology (1513)